CONCLUSION
In conclusion, concomitant administration of evogliptin and pioglitazone showed similar glucose lowering effets with those of evogliptin alone and no clinically significant pharmacokinetic interactions. Safe and tolerability of concomitant administration was comparable to administration of each drug alone.